SASMAR kündigt Akquisition von Aquatrove BioSciences, Inc. an März 16, 2017 Pharmaceutical company SASMAR acquires biotechnology company Aquatrove Biosciences, Inc. strengthening its global position in over-the-counter products that support health, fertility and reproduction.... Acquisitions Aquatrove Biosciences Read more
Pharmaunternehmen entscheidet sich für die Herstellung in Australien und stimuliert die Wirtschaft zu Hause März 16, 2017 Sasmar, an Australian biotechnology company, announced today that is has moved all manufacturing of its family planning lines to the Australian market. Sasmar CEO John-Michael Mancini said, With many... Australia economy family planning Read more